The need for high-throughput sample preparation in proteomics
Discover how the Resolvex A200 streamlines solid phase extraction (SPE) for proteomics with precise positive pressure technology, high-throughput automation, and reproducible results
Accelerating Science
New frontiers in drug discovery and development
The field of drug discovery and development is entering a new era, driven by powerful technologies that are transforming the way we understand and treat disease. Innovations in areas such as metabolomics and proteomics are providing deeper insights into biological processes than ever before, allowing for the design of more targeted therapeutic strategies. While biologics and other advanced therapies are offering new avenues for treating complex conditions with precision. Paired with this greater biological insight, we are also seeing rapid growth in automation and high-throughput screening technologies, which are set to further accelerate the identification of potential drug candidates.
Read on in this Accelerating Science Feature, as we explore these cutting-edge advancements in more detail, highlighting how they and the vital work of the scientists wielding them are shaping the future of medicine, opening up new possibilities for more effective, personalized treatments.
Featured interview
Standardizing metabolomics advances biomarker discovery
Discover how prioritizing reproducibility and method validation can empower researchers to unlock the full potential of metabolomics in advancing biomarker discovery and drug development.
Read articleEditorial articles
Featured resources
Applying quantitative proteomics for target system analysis in preclinical inflammatory bowel disease models
Inotiv discusses the application of quantitative proteomics in preclinical studies of inflammatory bowel disease (IBD), a chronic autoimmune disorder that affects millions of people worldwide.
Download resource
DAR determination using third generation conjugation method
Discover the evolution of antibody-drug conjugates (ADCs) from lysine to site-specific conjugation. Learn how YMC Europe’s YMC-Triart Bio C4 column ensures accurate DAR determination.
Download resource
Optimize your lab with PURELAB Flex water systems by ELGA
With reduced energy consumption, minimal environmental impact, and precision performance, learn how PURELAB Flex water systems by ELGA can enhance laboratory workflows globally.
Download resource
Enhancing research on bifunctional degraders
Discover how CETSA (Cellular Thermal Shift Assay) can elevate advances in monitoring molecular events to elucidate molecular dynamics and cellular effects. benefit pharmaceutical solutions.
Download resource
Streamline laboratory operations with Sample Scheduler for OpenLab
Explore how Agilent OpenLab CDS with Sample Scheduler simplifies lab operations, managing analyses across instruments and improving data quality without costly integrations.
Download resource
Automated protein quantification assays for the Opentrons Flex
Explore three Opentrons Flex™ protocols that have been developed to respectively perform common protein quantification methods: BCA protein assays, Bradford protein assays and BCA peptide quantification assays.
Download resource
Updates from ELRIG Drug Discovery 2024
Explore on-demand presentations and video interviews from Europe’s largest conference for the drug discovery community. Drug Discovery 2024 hosted scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling.
Editor's roundup: ELRIG Drug Discovery 2024
SelectScience had an incredible time at the ELRIG Drug Discovery 2024 conference. It was inspiring to hear some of the latest advancements in drug discovery and meet so many talented individuals in the industry. Here are a few take aways from our Pharma and Applied Science Editor Cameron Smith-Craig.
Watch video
Controlling in vivo drug transport using nanotechnology
Prof. Ijeoma Uchegbu, Professor of Pharmaceutical Nanoscience, UCL, and CSO at Nanomerics Ltd, discusses the advancements in nanotechnology over the past few decades and its pivotal role in transforming drug development.
Watch presentation
Latest news
Latest resources
Thank you to everyone who contributed to this Accelerating Science Feature
If you would like to share your story, scientific knowledge, and help to accelerate science, become a SelectScience member today, and if you would like to be involved in future SelectScience features, please do contact us.
Cameron Smith-Craig, Pharma and Applied Science Editor